DPP4 and Hypertension: A multivariate analysis was conducted to evaluate the relationship between selected comorbidities and their associated medications, specifically hypertension (ACEi and ARBs), diabetes (biguanides and DPP4 inhibitors), and metabolic disorders (statins).